Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Barrett B et al. 2006 UK | 599 ED patients aged >=18 years screening PAT (Paddington Alcohol Test) positive; consenting; English-speaking; resident within Greater London; no contact with alcohol services; not requesting help with alcohol problems. 312 randomised to control, 287 to brief intervention Control - standard care: health information leaflet 'Think about drink' including list of national help-lines and local alcohol support agencies Intervention - standard care plus appointment with alcohol health worker (mental health nurse): 30mins; assessment and discussion of current and previous drinking; help with resolving ambivalence regarding drinking; feedback about safe amounts of drinking and suggesting range of strategies to reduce alcohol consumption Usable sample of 159 control group and 131 intervention group with follow-up data available at 6 and 12 months | Cost-effectiveness analysis (parallel to Crawford et al. RCT) | Weekly alcohol consumption using Form 90-AQ and Steady Pattern Grid at 6 and 12 months | At 6 months significantly lower alcohol consumption in intervention vs. control group (59.7 units vs. 83.1 units, p=0.02); non-significant difference at 12 months (56.2 vs. 67.2) | Limited baseline data collected; small sample size (usable sample of 48% only); lower level of economic follow-up data than clinical outcome data. Personal costs incurred by patients not included in analyses, nor was cost of screening. Impact of variation in effectiveness measure (alcohol consumption) on ICER not examined. Service use and productivity losses evaluated by self-report – not validated against records |
Treatment cost (BI (Brief intervention) session, paperwork, onward referral) | £19; total cost per patient only £6 as only 41 of 131 (33%) in intervention group attended session | ||||
Cost of resource utilisation (alcohol services, hospital services, primary care, other social and non-statutory services, criminal justice) and productivity losses (days off work due to alcohol misuse) all via patient self-report. Costs from local and national sources. At 6 and 12 months | At 6 months average total cost of £3068 in intervention vs. £3122 in control group (p=0.95). At 12 months £5454 versus £5207 respectively (p=0.85). Biggest proportion of costs borne by health sector (49% and 53% in intervention and control group respectively) and social services (38% and 36% in intervention and control group respectively) | ||||
Cost-effectiveness (incremental cost-effectiveness ratio ICER) and cost-effectiveness acceptability curve | ICER = £22 per unit reduction in weekly alcohol consumption. Cost-effectiveness acceptability curve demonstrated ≥ 65% probability that brief intervention is more cost-effective than control treatment | ||||
Gentilello LM et al 2005 USA | Patients treated in ED or admitted to hospital after sustaining an injury; >=18 years; BAC (Blood alcohol concentration) >=100mg/dL or positive result on standard screening questionnaire (e.g. CAGE, MAST- Michigan Alcohol Screening Test, AUDIT) and consenting to intervention. No psychiatric illness or severe disability precluding participation in brief intervention | Cost-benefit analysis | Proportion of eligible patients (according to criteria defined in 'patient group') via literature review | 27% of all injured adult patients treated in the ED | Analysis restricted to direct medical costs – i.e. from perspective of hospitals, insurers and government agencies responsible for healthcare costs. Cost of follow-up care not included. Effectiveness data based on results of a single trial |
Cost of screening and brief intervention (Medicare fees) | Screening: $16/patient (cost of BAC and forms); BI: $38/ patient (fees for BI session and administration) | ||||
ED visits and hospitalisation rates for injury in problem-drinkers in a given year (former via literature review; latter based on national figures for ED patients requiring hospitalisation) | 28% of problem-drinkers return to ED for treatment of a new injury within 1 year. 6% require hospitalisation | ||||
Cost of ED visits and hospitalisation derived from MarketScan database of commercial claims | ED visit:$440; hospitalisation for average length of stay of 5.1 days: $16,852 | ||||
Effectiveness of BI in the context of acute injury at reducing subsequent health care use (via clinical Gentilello et al RCT) | 47% reduction in new injuries requiring ED treatment or admission; 48% reduction in injuries requiring hospitalisation over 3years follow-up | ||||
Cost analysis of universal screening and brief intervention (SBI) over 3 years | If SBI is offered, expected cost of screening, intervention and subsequent ED visits and hospitalisation = $600/patient. If BI is not offered, expected cost of subsequent ED visits and hospitalisation = $689/patient. | ||||
Cost savings analysis | Cost saving of $89 per patient screened, or $330 per patient offered BI. BI resulted in $3.81 in health care costs saved for every $1 spent on SBI | ||||
Sensitivity analyses (Monte Carlo analysis) | In 95% of simulations BI was either cost-saving or cost less than $24 per patient screened | ||||
Kunz FM et al. 2004 USA | 295 ED patients aged >=18 years screening positive to CAGE (score >=1); spoke English or Spanish; consented; no professional alcohol counselling within past 12 months; not in police custody; medical treatment and/or cognitive impairment not precluding interview. 151 randomised to standard care (SC), 144 to brief intervention (BI) SC – standard care plus packet of health information BI – SC plus 15-20min interview by health promotion advocate. Established rapport with patient; discussed alcohol use; explored pros and cons of use (decisional balance) using reflective listening; assessed readiness to change; and negotiated plan for change based on the patient's perception of readiness. Participants given copy of plan for change Usable sample of 104 control group and 90 intervention group with follow-up data available at 3 months | Cost-effectiveness analysis (parallel to Bazargan-Hejazi et al. RCT) | Alcohol consumption using AUDIT (Alcohol Use Disorders Identification Test) score, average number of weekly drinks and heavy drinking in past month at baseline and 3 months | Intervention group had lower follow-up AUDIT score vs. control group (difference = 2.45); consumed fewer drinks per week (difference = 2.89 drinks/week); and were less likely to report heavy episodic drinking (difference = 10.34% points less). Regression analysis after controlling for baseline variables showed intervention was non-significant predictor of all 3 outcomes | Include weaknesses of RCT [i.e. selection bias as 'randomisation' not truly random (by alternative allocation) and high refusal rate (40%). Sampling period limited to 9am-6pm week days. High loss to follow-up (37%). Small sample size. Short follow-up period. Patients not blinded; investigators not blinded? Only one outcome measured]. High loss to follow-up (34%). Wide variation in ICER with changes in effectiveness value (alcohol consumption). Only cost of SBI program analysed - cost of using other services / resources not examined |
Cost of screening and brief intervention program (SBI) using DATCAP (The Drug Abuse Treatment Cost Analysis Program) - data collection instrument and interview guide; measures accounting costs (actual expenditures of a treatment program and depreciation of its resources) and economic costs (full value of all resources i.e. opportunity costs) | $631.89 per SBI participant; 79% on screening; 21% on intervention. Total program cost $91, 624; 60% on personnel salaries and benefits; 35% on overhead and patient incentives; 5% on miscellaneous supplies and equipment | ||||
Cost-effectiveness (ICER - incremental cost-effectiveness ratio) | Cost-effectiveness ratio 257.9 for AUDIT score; 218.7 for average weekly number of drinks; 61.11 for heavy drinking |